CPRX

Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Top Estimates

Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Catalyst Pharmaceutical (CPRX) Reports Next Week: What Awaits?

Catalyst Pharmaceuticals to Hold Second Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 10th, 2021

Catalyst Pharmaceuticals Announces Issuance of U.S. Patent 11,060,128 a Method of Use Patent with Claims Covering Firdapse®

Catalyst (CPRX) Thrives on Firdapse But Overdependence Concerns